HALO
Halozyme Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
Latest data update time: Updated on 2026-01-31
5.59 / 10Overall Score
NeturalInvestment Rating
5.59 / 10Overall Score
NeturalInvestment Rating
Is HALO a Good Buy Right Now?
- Based on a composite score of 5.59/10, we rate HALO as a Netural. Our analysis breaks down into 5.93/10 for Fundamentals, 4.50/10 for Technicals, and 5.97/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Technical Analysis of HALO?
Is HALO undervalued or overvalued?
What is the analyst consensus for HALO?
Is HALO a Good Buy Right Now?
- Based on a composite score of 5.59/10, we rate HALO as a Netural. Our analysis breaks down into 5.93/10 for Fundamentals, 4.50/10 for Technicals, and 5.97/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is HALO undervalued or overvalued?
Technical Analysis of HALO?
What is the analyst consensus for HALO?
